<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000535498">
  <TermName>topoisomerase II inhibitor RTA 744</TermName>
  <TermPronunciation>(TOH-poh-i-SAH-meh-rays ... in-HIH-bih-ter ...)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance being studied in the treatment of adult brain tumors. Topoisomerase II inhibitor RTA 744 crosses the blood-brain barrier and blocks an enzyme needed for cancer growth. It is a type of topoisomerase inhibitor. Also called RTA 744.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000718388" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;topoisomerase II inhibitor RTA 744&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000718389" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;inhibidor de la topoisomerasa II RTA 744&quot;" language="es" id="_4"/>
  <SpanishTermName>inhibidor de la topoisomerasa II RTA 744</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento de los tumores cerebrales en adultos. El inhibidor de la topoisomerasa II RTA 744 cruza la barrera hematoencefálica y bloquea una enzima que el cáncer necesita para crecer. Es  un tipo de inhibidor de la topoisomerasa. También se llama RTA 744.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2007-02-12</DateFirstPublished>
  <DateLastModified>2008-11-14</DateLastModified>
</GlossaryTerm>
